J, T., Y, W., SN, L., K, L., JD, C., R, W., . . . P, G. (2025). Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nature medicine, 31(5), 1509. https://doi.org/10.1038/s41591-025-03579-w
Chicago Style (17th ed.) CitationJ, Tie, et al. "Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer: 5-year Outcomes of the Randomized DYNAMIC Trial." Nature Medicine 31, no. 5 (2025): 1509. https://doi.org/10.1038/s41591-025-03579-w.
MLA (9th ed.) CitationJ, Tie, et al. "Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer: 5-year Outcomes of the Randomized DYNAMIC Trial." Nature Medicine, vol. 31, no. 5, 2025, p. 1509, https://doi.org/10.1038/s41591-025-03579-w.